Inventor · disambiguated record
Takehisa Kitazawa
Also filed as: KITAZAWA TAKEHISA
9 granted patents·17 pending applications·268 citations·filing 2000–2025
87Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD21SAITO HIROYUKI2IGAWA TOMOYUKI1KITAZAWA TAKEHISA1PUBLIC UNIV CORPORATION NARA MEDICAL UNIV1
Top patents by PatentIndex Score
26 records- 0196US9334331B2Bispecific antibodiesIGAWA TOMOYUKI·Filed 2011·Granted May 10, 2016·221 cites·33 claims
- 0295US10450381B2Methods of treatment that include the administration of bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·28 cites·84 claims
- 0393US11827699B2Methods for producing antibodies promoting disappearance of antigens having plurality of biological activitiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 28, 2023·8 cites·20 claims
- 0492US2025382387A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0589US2024376228A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0688US2024059795A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0784US2023212315A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0883US11214623B2Antibody capable of neutralizing substance having activity alternative to function of coagulation factor VIII (FVIII)CHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jan 4, 2022·3 cites·10 claims
- 0983US11150254B2Method for measuring reactivity of FVIIICHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 19, 2021·3 cites·34 claims
- 1081US2022267470A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1177US2025154285A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1270US2019315884A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1369US9175091B2Monoclonal antibody capable of binding to anexelekto, and use thereofKITAZAWA TAKEHISA·Filed 2008·Granted Nov 3, 2015·3 cites·7 claims
- 1464US2014370018A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1564US2014037632A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1663US2017022293A1Nucleic acid encoding bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1757US2015050269A1Antigen-binding molecule promoting disappearance of antigens having plurality of biological activitiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Application pending·0 cites
- 1856US8062638B1Prevention and treatment of diseases associated with blood coagulationSAITO HIROYUKI·Filed 2000·Granted Nov 22, 2011·2 cites·3 claims
- 1954US2017022270A1Antigen-binding molecule promoting disappearance of antigens having plurality of biological activitiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 2051US2012073002A1Prevention and treatment of blood coagulation-related disasesSAITO HIROYUKI·Filed 2011·Application pending·0 cites
- 2151US2019248921A1Treatment for hemorrhagic diseases by anti-protein-c antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 2251US2016229922A1Treatment for hemorrhagic diseases by anti-protein-c antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 2349US11078518B2Method for evaluating blood coagulation reactionCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Aug 3, 2021·0 cites·8 claims
- 2448US10302626B2Method for evaluating coagulation ability of blood specimen, and reagent, reagent kit and device to be used thereinPUBLIC UNIV CORPORATION NARA MEDICAL UNIV·Filed 2017·Granted May 28, 2019·0 cites·7 claims
- 2542US2006233786A1Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparationCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Application pending·0 cites
- 2637US2016053019A1Monoclonal antibody capable of binding to anexelekto, and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takehisa Kitazawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →